XWS-32826-62274
4 vaccinations
2 coded responses
44 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 402 / KY
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
M8R-13931-66086
Child or adolescent in my care · Female · 2022-06-25
MLA-21195-95832
Child or adolescent in my care · Male · 2022-06-25
EBK-31151-60529
Child or adolescent in my care · Male · 2022-06-25
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Registered in v-safe
- 2020-12-29
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, NauseaAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-17
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
-
2021-07-09
Survey response — 6 months, dose 2MedDRA: Malignant melanoma stage I — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with stage 1a melanomaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-09
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-07-13
Call successfulDoes not wish to fill out VAERS report
-
2021-09-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-10
- 2021-12-29
- 2022-03-30
-
2022-09-25
Dose 4 — Pfizer-BioNTech
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-10-23
- 2022-10-30
-
2022-11-06
Survey response — day 42, dose 4MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend schoolFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-25
Health check-in — 3 months, dose 4Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Got Covid in NovemberAdult check-in · check-in free text available
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-25 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-10 | priority 2/3 | |
| 2021-07-09 | Successful 2021-07-13 |
Does not wish to fill out VAERS report |
Free text
Release 9 — 6 months, dose 2
Symptoms: Diagnosed with stage 1a melanoma
Release 12 — day 42, dose 4
Symptoms: Cold symptoms
Release 12 — 3 months, dose 4
Symptoms: Got Covid in November
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malignant melanoma stage I | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release